Just Treatment
@justtreatment.org
We campaign to put patients and the #NHS before profit. ✊
4/ It's time for a proper rethink of all of the assumptions about the benefit of the monopoly pharma model to taxpayers, patients and the NHS.
October 17, 2025 at 9:09 AM
4/ It's time for a proper rethink of all of the assumptions about the benefit of the monopoly pharma model to taxpayers, patients and the NHS.
3/ These tax breaks come with promises to invest. But those promises get broken.
GSK pushed for the scheme, pledged a £500m Ulverston factory - then scrapped it and closed the site in 2025. HMRC says the scheme didn’t change most big firms’ decisions. So why trust them now?
GSK pushed for the scheme, pledged a £500m Ulverston factory - then scrapped it and closed the site in 2025. HMRC says the scheme didn’t change most big firms’ decisions. So why trust them now?
October 17, 2025 at 9:09 AM
3/ These tax breaks come with promises to invest. But those promises get broken.
GSK pushed for the scheme, pledged a £500m Ulverston factory - then scrapped it and closed the site in 2025. HMRC says the scheme didn’t change most big firms’ decisions. So why trust them now?
GSK pushed for the scheme, pledged a £500m Ulverston factory - then scrapped it and closed the site in 2025. HMRC says the scheme didn’t change most big firms’ decisions. So why trust them now?
2/ ‘Patent Box’ is a special tax break on patent profits.
It costs £2bn+ a year.
Over half goes to just 10 companies. GSK - has taken 27% since 2013: £3.4bn total, £486m in 2024.
It costs £2bn+ a year.
Over half goes to just 10 companies. GSK - has taken 27% since 2013: £3.4bn total, £486m in 2024.
October 17, 2025 at 9:09 AM
2/ ‘Patent Box’ is a special tax break on patent profits.
It costs £2bn+ a year.
Over half goes to just 10 companies. GSK - has taken 27% since 2013: £3.4bn total, £486m in 2024.
It costs £2bn+ a year.
Over half goes to just 10 companies. GSK - has taken 27% since 2013: £3.4bn total, £486m in 2024.